Form D · Biotechnology

OXOS Series #7 Holdings, LLC

Atlanta, GA · CIK 0001922447

Offering snapshot reported Jan 26, 2023 · SEC filing

Reported sold
$7.75M
Offering amount: $10M
Investors reported
79
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 8, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.88M$7.75MApr 19, 2022: $1,849,000.00Apr 19, 2022Jan 26, 2023: $7,753,500.00Jan 26, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,849,000 → $7,753,500
  • Reported investors23 → 79

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 26, 2023Amendment$7,753,500$5,904,500vs Apr 19, 202279SEC filing
Apr 19, 2022Initial$1,849,000No comparison23SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-442429

Source: Form D, filed Jan 26, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joshua Hix Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1230 Peachtree St Ne Suite 300
Atlanta, GA, 30309